8-K · 2026-10-07
Spyre Therapeutics has filed an 8-K with the SEC for a $350 million public offering of common stock, which will fund its clinical programs.
| Name | Spyre Therapeutics, Inc. |
|---|---|
| CIK | 0001636282 |
| Tickers | SYRE |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 464312787 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 6176515940 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Spyre Therapeutics has filed an 8-K with the SEC for a $350 million public offering of common stock, which will fund its clinical programs.
823 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-03 | 8-K | 8-K | 2.02,9.01 | 0001636282-26-000132 | 001-37722 | 261517221 | 34 | 294619 | 1 | 1 |
| 2026-11-03 | 10-Q | 10-Q | 0001636282-26-000131 | 001-37722 | 261517186 | 34 | 10511851 | 1 | 1 | |
| 2026-10-09 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-115087 | 005-89456 | 261453548 | 34 | 19375 | |||
| 2026-10-07 | 8-K | 8-K | 1.01,9.01 | 0001628280-26-065291 | 001-37722 | 261445485 | 34 | 590973 | 1 | 1 |
| 2026-10-06 | 424B5 | 424B5 | 0001628280-26-065249 | 333-297063 | 261444591 | 33 | 809056 | 1 | 1 | |
| 2026-10-05 | 424B5 | 424B5 | 0001628280-26-064924 | 333-297063 | 261440477 | 33 | 659285 | |||
| 2026-10-02 | 4 | FORM 4 | 0001636282-26-000119 | 16875 | ||||||
| 2026-10-02 | 4 | FORM 4 | 0001636282-26-000118 | 14798 | ||||||
| 2026-10-02 | 4 | FORM 4 | 0001636282-26-000117 | 22415 | ||||||
| 2026-10-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009978 | 001-37722 | 261431956 | 33 | 6438 | |||
| 2026-10-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009971 | 001-37722 | 261431811 | 33 | 6774 | |||
| 2026-10-01 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-112828 | 005-89456 | 261431350 | 34 | 16628 | |||
| 2026-09-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009876 | 001-37722 | 261427157 | 33 | 7910 | |||
| 2026-09-08 | 8-K | 8-K | 7.01,8.01,9.01 | 0001636282-26-000113 | 001-37722 | 261363444 | 34 | 237732 | 1 | 1 |
| 2026-09-03 | 4 | FORM 4 | 0001636282-26-000111 | 20156 | ||||||
| 2026-09-03 | 4 | FORM 4 | 0001636282-26-000109 | 17161 | ||||||
| 2026-09-03 | 4 | FORM 4 | 0001636282-26-000107 | 11454 | ||||||
| 2026-09-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008970 | 001-37722 | 261351613 | 33 | 5155 | |||
| 2026-08-25 | 8-K | 8-K | 7.01,8.01,9.01 | 0001636282-26-000105 | 001-37722 | 261315697 | 34 | 225629 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-352655 | 005-89456 | 261283808 | 34 | 11143 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000157 | 005-89456 | 261276297 | 34 | 10628 | |||
| 2026-08-10 | 4 | FORM 4 | 0001636282-26-000102 | 13205 | ||||||
| 2026-08-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007821 | 001-37722 | 261254950 | 33 | 4902 | |||
| 2026-08-07 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007819 | 001-37722 | 261254946 | 33 | 4898 | |||
| 2026-08-05 | 4 | FORM 4 | 0001636282-26-000100 | 13064 | ||||||
| 2026-08-05 | 4 | FORM 4 | 0001636282-26-000099 | 13353 | ||||||
| 2026-08-04 | 8-K | 8-K | 2.02,9.01 | 0001636282-26-000098 | 001-37722 | 261238560 | 34 | 290669 | 1 | 1 |
| 2026-08-04 | 10-Q | 10-Q | 0001636282-26-000096 | 001-37722 | 261238397 | 34 | 10496021 | 1 | 1 | |
| 2026-08-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-007571 | 001-37722 | 261233918 | 33 | 7284 | |||
| 2026-07-02 | 4 | FORM 4 | 0001636282-26-000088 | 11663 | ||||||
| 2026-07-02 | 4 | FORM 4 | 0001636282-26-000087 | 11133 | ||||||
| 2026-07-02 | 4 | FORM 4 | 0001636282-26-000086 | 9554 | ||||||
| 2026-07-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006779 | 001-37722 | 261146318 | 33 | 6440 | |||
| 2026-06-26 | 4 | FORM 4 | 0001853327-26-000008 | 10923 | ||||||
| 2026-06-26 | S-3ASR | S-3ASR | 0001628280-26-045742 | 333-297063 | 261129020 | 33 | 1405491 | 1 | 1 | |
| 2026-06-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006485 | 001-37722 | 261121854 | 33 | 7149 | |||
| 2026-06-23 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-076969 | 001-37722 | 261112874 | 33 | 6313 | |||
| 2026-06-23 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-076967 | 19148 | ||||||
| 2026-06-23 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-076961 | 005-89456 | 261112852 | 34 | 19236 | |||
| 2026-06-23 | 4 | FORM 4 | 0001636282-26-000084 | 4891 | ||||||
| 2026-06-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-006375 | 001-37722 | 261107693 | 33 | 5872 | |||
| 2026-06-15 | 8-K | 8-K | 7.01,8.01,9.01 | 0001636282-26-000083 | 001-37722 | 261089093 | 34 | 220518 | 1 | 1 |
| 2026-06-03 | 4 | FORM 4 | 0001636282-26-000078 | 8763 | ||||||
| 2026-06-03 | 4 | FORM 4 | 0001636282-26-000077 | 9554 | ||||||
| 2026-06-03 | 4 | FORM 4 | 0001636282-26-000076 | 13523 | ||||||
| 2026-06-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005572 | 001-37722 | 261061067 | 33 | 6551 | |||
| 2026-06-01 | 8-K | 8-K | 8.01,9.01 | 0001636282-26-000075 | 001-37722 | 261050399 | 34 | 190429 | 1 | 1 |
| 2026-05-29 | 4 | FORM 4 | 0001636282-26-000069 | 10222 | ||||||
| 2026-05-29 | 4 | FORM 4 | 0001636282-26-000068 | 5759 | ||||||
| 2026-05-29 | 4 | FORM 4 | 0001636282-26-000067 | 5732 | ||||||
| 2026-05-29 | 4 | FORM 4 | 0001636282-26-000066 | 5745 | ||||||
| 2026-05-29 | 4 | FORM 4 | 0001636282-26-000065 | 5729 | ||||||
| 2026-05-29 | 4 | FORM 4 | 0001859810-26-000002 | 5738 | ||||||
| 2026-05-29 | 8-K | 8-K | 5.02,5.07,9.01 | 0001636282-26-000056 | 001-37722 | 261045514 | 34 | 345462 | 1 | 1 |
| 2026-05-08 | 4 | FORM 4 | 0001636282-26-000053 | 10981 | ||||||
| 2026-05-08 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004262 | 001-37722 | 26958727 | 33 | 5088 | |||
| 2026-05-05 | 8-K | 8-K | 2.02,9.01 | 0001636282-26-000051 | 001-37722 | 26940526 | 34 | 278103 | 1 | 1 |
| 2026-05-05 | 10-Q | 10-Q | 0001636282-26-000050 | 001-37722 | 26940510 | 34 | 10639142 | 1 | 1 | |
| 2026-05-01 | 4 | FORM 4 | 0001853327-26-000005 | 9298 | ||||||
| 2026-05-01 | 4 | FORM 4 | 0002038798-26-000004 | 19964 | ||||||
| 2026-05-01 | 4 | FORM 4 | 0001758363-26-000009 | 15256 | ||||||
| 2026-05-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003923 | 001-37722 | 26933422 | 33 | 5708 | |||
| 2026-05-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003922 | 001-37722 | 26933420 | 33 | 6746 | |||
| 2026-04-22 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-170304 | 005-89456 | 26883604 | 34 | 595393 | |||
| 2026-04-20 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-045578 | 005-89456 | 26876284 | 34 | 19751 | |||
| 2026-04-16 | 8-K | 8-K | 1.01,9.01 | 0001628280-26-025508 | 001-37722 | 26867750 | 34 | 558501 | 1 | 1 |
| 2026-04-16 | 424B5 | 424B5 | 0001628280-26-025310 | 333-293600 | 26865088 | 33 | 528869 | |||
| 2026-04-13 | 424B5 | 424B5 | 0001628280-26-024940 | 333-293600 | 26858607 | 33 | 522828 | |||
| 2026-04-13 | 8-K | 8-K | 2.02,8.01 | 0001628280-26-024906 | 001-37722 | 26858095 | 34 | 155496 | 1 | 1 |
| 2026-04-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-26-024831 | 001-37722 | 26856478 | 34 | 4846568 | 1 | 1 |
| 2026-04-10 | ARS | ARS | 0001636282-26-000043 | 001-37722 | 26854993 | 34 | 125660354 | |||
| 2026-04-10 | DEFA14A | DEFA14A | 0001636282-26-000041 | 001-37722 | 26854827 | 34 | 502995 | |||
| 2026-04-10 | DEF 14A | DEF 14A | 0001636282-26-000039 | 001-37722 | 26854759 | 34 | 5199192 | 1 | 1 | |
| 2026-04-03 | 4 | FORM 4 | 0001758363-26-000007 | 7654 | ||||||
| 2026-04-03 | 4 | FORM 4 | 0001636282-26-000030 | 8673 | ||||||
| 2026-04-03 | 4 | FORM 4 | 0001853327-26-000003 | 11662 | ||||||
| 2026-04-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003140 | 001-37722 | 26828900 | 33 | 4927 | |||
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002337 | 005-89456 | 26804591 | 34 | 7462 | |||
| 2026-03-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000722 | 333-285341 | 26724019 | 33 | 1895 | ||
| 2026-03-03 | 4 | FORM 4 | 0001636282-26-000028 | 11524 | ||||||
| 2026-03-03 | 4 | FORM 4 | 0001636282-26-000026 | 7516 | ||||||
| 2026-03-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-002111 | 001-37722 | 26715498 | 33 | 5138 | |||
| 2026-03-02 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001983 | 001-37722 | 26708275 | 33 | 6832 | |||
| 2026-02-27 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000695 | 333-293600 | 26703155 | 33 | 1882 | ||
| 2026-02-27 | POS AM | POS AM | 0001628280-26-012785 | 333-285341 | 26699471 | 33 | 30045 | |||
| 2026-02-25 | CORRESP | filename1.htm | 0001628280-26-011614 | 9442 | ||||||
| 2026-02-25 | UPLOAD | filename1.pdf | 0000000000-26-001931 | 333-293600 | 40261 | |||||
| 2026-02-19 | S-3 | S-3 | 0001628280-26-009814 | 333-293600 | 26654988 | 33 | 1078686 | 1 | 1 | |
| 2026-02-19 | S-8 | S-8 | 0001636282-26-000024 | 333-293589 | 26654519 | 33 | 258827 | 1 | 1 | |
| 2026-02-19 | 8-K | 8-K | 2.02,9.01 | 0001636282-26-000022 | 001-37722 | 26654346 | 34 | 294028 | 1 | 1 |
| 2026-02-19 | 10-K | 10-K | 0001636282-26-000020 | 001-37722 | 26654198 | 34 | 17902651 | 1 | 1 | |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-26-002024 | 005-89456 | 26641469 | 34 | 14324 | |||
| 2026-02-04 | 4 | FORM 4 | 0001758363-26-000005 | 7727 | ||||||
| 2026-01-23 | 4 | FORM 4 | 0001779990-26-000002 | 4814 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001636282-26-000004 | 5610 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001636282-26-000003 | 5608 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001636282-26-000002 | 5573 | ||||||
| 2026-01-13 | 4 | FORM 4 | 0001636282-26-000001 | 5631 | ||||||
| 2026-01-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-009894 | 001-37722 | 26524890 | 34 | 16092960 | 1 | 1 |
| 2026-01-06 | 4 | FORM 4 | 0001758363-26-000002 | 9423 | ||||||
| 2025-12-03 | 4 | FORM 4 | 0001758363-25-000003 | 7524 | ||||||
| 2025-11-05 | 4 | FORM 4 | 0001636282-25-000106 | 7525 | ||||||
| 2025-11-04 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001636282-25-000104 | 001-37722 | 251449138 | 34 | 631016 | 1 | 1 |
| 2025-11-04 | 10-Q | 10-Q | 0001636282-25-000102 | 001-37722 | 251448813 | 34 | 8492538 | 1 | 1 | |
| 2025-11-03 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008390 | 001-37722 | 251444473 | 33 | 4992 | |||
| 2025-10-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-100449 | 005-89456 | 251401432 | 34 | 30000 | |||
| 2025-10-15 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-240237 | 001-37722 | 251394843 | 34 | 467171 | 1 | 1 |
| 2025-10-14 | 424B5 | 424B5 | 0001193125-25-239143 | 333-285341 | 251392551 | 33 | 450415 | |||
| 2025-10-14 | 424B5 | 424B5 | 0001193125-25-237918 | 333-285341 | 251389441 | 33 | 478672 | |||
| 2025-10-14 | 8-K | 8-K | 2.02 | 0001193125-25-237904 | 001-37722 | 251389416 | 34 | 147568 | 1 | 1 |
| 2025-09-03 | 4 | FORM 4 | 0001636282-25-000095 | 6096 | ||||||
| 2025-08-05 | S-8 | S-8 | 0001636282-25-000093 | 333-289255 | 251185257 | 33 | 265264 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0001636282-25-000091 | 001-37722 | 251185021 | 34 | 362787 | 1 | 1 |
| 2025-08-05 | 10-Q | 10-Q | 0001636282-25-000089 | 001-37722 | 251184915 | 34 | 9046513 | 1 | 1 | |
| 2025-07-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-001050 | 005-89456 | 251160677 | 34 | 6483 | |||
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002469 | 005-89456 | 251128426 | 34 | 11110 | |||
| 2025-06-17 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-141756 | 001-37722 | 251051832 | 34 | 11335028 | 1 | 1 |
| 2025-06-02 | 4 | FORM 4 | 0001636282-25-000069 | 14429 | ||||||
| 2025-06-02 | 4 | FORM 4 | 0001636282-25-000068 | 5567 | ||||||
| 2025-06-02 | 4 | FORM 4 | 0001636282-25-000067 | 5573 | ||||||
| 2025-06-02 | 4 | FORM 4 | 0001636282-25-000066 | 5581 | ||||||
| 2025-06-02 | 4 | FORM 4 | 0001636282-25-000065 | 5584 | ||||||
| 2025-06-02 | 4 | FORM 4 | 0001636282-25-000064 | 5622 | ||||||
| 2025-06-02 | 8-K | 8-K | 5.07,9.01 | 0001636282-25-000063 | 001-37722 | 251014831 | 34 | 162481 | 1 | 1 |
| 2025-06-02 | UPLOAD | filename1.pdf | 0000000000-25-005782 | 001-37722 | 39844 | |||||
| 2025-05-21 | CORRESP | filename1.htm | 0001636282-25-000054 | 71266 | ||||||
| 2025-05-09 | UPLOAD | filename1.pdf | 0000000000-25-004985 | 001-37722 | 44137 | |||||
| 2025-05-08 | 8-K | 8-K | 2.02,9.01 | 0001636282-25-000050 | 001-37722 | 25925941 | 34 | 348483 | 1 | 1 |
| 2025-05-08 | 10-Q | 10-Q | 0001636282-25-000049 | 001-37722 | 25925806 | 34 | 13147068 | 1 | 1 | |
| 2025-05-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-006773 | 005-89456 | 25903293 | 34 | 28264 | |||
| 2025-04-14 | ARS | ARS | 0001636282-25-000040 | 001-37722 | 25836506 | 34 | 33979645 | |||
| 2025-04-14 | DEFA14A | DEFA14A | 0001636282-25-000039 | 001-37722 | 25836470 | 34 | 349970 | |||
| 2025-04-14 | DEF 14A | DEF 14A | 0001636282-25-000038 | 001-37722 | 25836423 | 34 | 4075819 | 1 | 1 | |
| 2025-03-13 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000659 | 333-281975 | 25737471 | 33 | 1902 | ||
| 2025-03-07 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000613 | 333-285341 | 25721946 | 33 | 1889 | ||
| 2025-03-07 | POS AM | POS AM | 0001628280-25-011345 | 333-281975 | 25720755 | 33 | 25839 | |||
| 2025-03-06 | 8-K | 8-K | 4.01,9.01 | 0001193125-25-048423 | 001-37722 | 25715429 | 34 | 158416 | 1 | 1 |
| 2025-03-05 | CORRESP | filename1.htm | 0001628280-25-010520 | 85000 | ||||||
| 2025-03-04 | UPLOAD | filename1.pdf | 0000000000-25-002409 | 333-285341 | 40310 | |||||
| 2025-02-27 | S-3 | S-3 | 0001628280-25-008686 | 333-285341 | 25679284 | 33 | 1515522 | 1 | 1 | |
| 2025-02-27 | S-8 | S-8 | 0001636282-25-000024 | 333-285332 | 25678928 | 33 | 273657 | 1 | 1 | |
| 2025-02-27 | 8-K | 8-K | 2.02,9.01 | 0001636282-25-000022 | 001-37722 | 25678736 | 34 | 373311 | 1 | 1 |
| 2025-02-27 | 10-K | 10-K | 0001636282-25-000020 | 001-37722 | 25678562 | 34 | 18192542 | 1 | 1 | |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-004231 | 005-89456 | 25631547 | 34 | 25105 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-021223 | 005-89456 | 25628912 | 34 | 10918 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-020484 | 005-89456 | 25623665 | 34 | 10380 | |||
| 2025-01-17 | 4 | FORM 4 | 0001636282-25-000010 | 5613 | ||||||
| 2025-01-17 | 4 | FORM 4 | 0001636282-25-000009 | 5576 | ||||||
| 2025-01-17 | 4 | FORM 4 | 0001636282-25-000008 | 359099 | ||||||
| 2025-01-17 | 4 | FORM 4 | 0001636282-25-000007 | 5610 | ||||||
| 2025-01-14 | 4 | FORM 4 | 0001636282-25-000002 | 361105 | ||||||
| 2025-01-13 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-25-005015 | 001-37722 | 25524917 | 34 | 21798709 | 1 | 1 |
| 2024-11-19 | 8-K | 8-K | 1.01,9.01 | 0001628280-24-048527 | 001-37722 | 241477279 | 34 | 653738 | 1 | 1 |
| 2024-11-19 | 424B5 | 424B3 | 0001628280-24-048482 | 333-281975 | 241476795 | 33 | 544466 | |||
| 2024-11-18 | 424B5 | 424B5 | 0001628280-24-048293 | 333-281975 | 241472369 | 33 | 565845 | |||
| 2024-11-18 | 10-Q/A | 10-Q/A | 0001636282-24-000113 | 001-37722 | 241471533 | 34 | 8273517 | 1 | 1 | |
| 2024-11-18 | 10-Q/A | 10-Q/A | 0001636282-24-000111 | 001-37722 | 241471513 | 34 | 7719729 | 1 | 1 | |
| 2024-11-18 | 10-Q/A | 10-Q/A | 0001636282-24-000109 | 001-37722 | 241471478 | 34 | 6105451 | 1 | 1 | |
| 2024-11-18 | 10-K/A | 10-K | 0001636282-24-000107 | 001-37722 | 241471431 | 34 | 10779209 | 1 | 1 | |
| 2024-11-18 | 8-K | 8-K | 4.02,8.01 | 0001636282-24-000105 | 001-37722 | 241471410 | 34 | 197758 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119333 | 005-89456 | 241464787 | 34 | 151338 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001193125-24-258682 | 005-89456 | 241463297 | 34 | 60206 | |||
| 2024-11-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-045810 | 005-89456 | 241461810 | 34 | 87407 | |||
| 2024-11-14 | SC 13G/A | deeptrack-syre093024a2.htm | 0001172661-24-004773 | 005-89456 | 241457896 | 34 | 103380 | |||
| 2024-11-14 | SC 13G/A | SPYRE THERAPEUTICS, INC. | 0000902664-24-006526 | 005-89456 | 241457825 | 34 | 59109 | |||
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002912 | 005-89456 | 241444974 | 34 | 8392 | |||
| 2024-11-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001628280-24-046860 | 001-37722 | 241443342 | 34 | 4750891 | 1 | 1 |
| 2024-11-08 | 4 | FORM 4 | 0001636282-24-000089 | 5451 | ||||||
| 2024-11-08 | SC 13G | us00773j2024_110824.txt | 0002012383-24-003588 | 005-89456 | 241439705 | 34 | 13924 | |||
| 2024-11-07 | S-8 | S-8 | 0001636282-24-000087 | 333-283065 | 241435926 | 33 | 284665 | |||
| 2024-11-07 | 8-K | 8-K | 2.02,9.01 | 0001636282-24-000085 | 001-37722 | 241435564 | 34 | 361312 | 1 | 1 |
| 2024-11-07 | 10-Q | 10-Q | 0001636282-24-000083 | 001-37722 | 241435358 | 34 | 10163353 | 1 | 1 | |
| 2024-10-28 | 4 | FORM 4 | 0001636282-24-000070 | 4921 | ||||||
| 2024-10-25 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007878 | 001-37722 | 241397405 | 33 | 4967 | |||
| 2024-10-23 | SC 13G | SCHEDULE 13G | 0001683168-24-007319 | 005-89456 | 241388829 | 34 | 39387 | |||
| 2024-10-22 | SC 13G | us00773j2024_102224.txt | 0002012383-24-001245 | 005-89456 | 241386098 | 34 | 13912 | |||
| 2024-10-15 | 8-K | 8-K | 1.01,7.01,8.01,9.01 | 0001193125-24-237150 | 001-37722 | 241369027 | 34 | 18990971 | 1 | 1 |
| 2024-10-02 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-10-02 16:15:00 | 9999999995-24-003068 | 333-282252 | 241349719 | 33 | 1890 | ||
| 2024-10-01 | 4 | FORM 4 | 0001636282-24-000068 | 5671 | ||||||
| 2024-10-01 | 3 | FORM 3 | 0001636282-24-000066 | 319370 | ||||||
| 2024-09-30 | CORRESP | filename1.htm | 0001628280-24-041574 | 90721 | ||||||
| 2024-09-26 | UPLOAD | filename1.pdf | 0000000000-24-010954 | 333-282252 | 40208 | |||||
| 2024-09-20 | S-3 | S-3 | 0001628280-24-041021 | 333-282252 | 241313417 | 33 | 495451 | |||
| 2024-09-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-09-18 16:30:00 | 9999999995-24-002887 | 333-281975 | 241308730 | 33 | 1890 | ||
| 2024-09-13 | CORRESP | filename1.htm | 0001628280-24-040360 | 89918 | ||||||
| 2024-09-12 | UPLOAD | filename1.pdf | 0000000000-24-010311 | 333-281975 | 40204 | |||||
| 2024-09-06 | S-3 | S-3 | 0001628280-24-039683 | 333-281975 | 241284548 | 33 | 1496979 | |||
| 2024-09-05 | 4 | FORM 4 | 0001636282-24-000062 | 6128 | ||||||
| 2024-08-08 | 424B3 | 424B3 | 0001193125-24-196209 | 333-278810 | 241185690 | 33 | 1272650 | |||
| 2024-08-08 | 8-K/A | 8-K | 8.01 | 0001636282-24-000058 | 001-37722 | 241185458 | 34 | 163475 | 1 | 1 |
| 2024-08-07 | 8-K | 8-K | 2.02,9.01 | 0001636282-24-000053 | 001-37722 | 241184040 | 34 | 357824 | 1 | 1 |
| 2024-08-07 | 10-Q | 10-Q | 0001636282-24-000051 | 001-37722 | 241183628 | 34 | 10453691 | 1 | 1 | |
| 2024-06-10 | SC 13G/A | filing.txt | 0000315066-24-001784 | 005-89456 | 241031644 | 34 | 8378 | |||
| 2024-05-30 | 8-K | 8-K | 7.01 | 0001193125-24-150395 | 001-37722 | 241006004 | 34 | 148212 | 1 | 1 |
| 2024-05-16 | 4 | 4 | 0000950170-24-061084 | 12509 | ||||||
| 2024-05-16 | 4 | 4 | 0000950170-24-061083 | 5464 | ||||||
| 2024-05-16 | 4 | 4 | 0000950170-24-061082 | 5513 | ||||||
| 2024-05-16 | 4 | 4 | 0000950170-24-061085 | 5458 | ||||||
| 2024-05-16 | 4 | 4 | 0000950170-24-061080 | 5475 | ||||||
| 2024-05-16 | 3 | 3 | 0000950170-24-061074 | 10481 | ||||||
| 2024-05-15 | 424B3 | 424B3 | 0001193125-24-139363 | 333-278810 | 24950438 | 33 | 799725 | |||
| 2024-05-15 | 8-K | 8-K | 1.01,5.02,5.03,5.07,7.01,9.01 | 0001193125-24-138893 | 001-37722 | 24947181 | 34 | 273146 | 1 | 1 |
| 2024-05-09 | 8-K | 8-K | 2.02,9.01 | 0001636282-24-000039 | 001-37722 | 24930720 | 34 | 339649 | 1 | 1 |
| 2024-05-09 | 10-Q | 10-Q | 0001636282-24-000037 | 001-37722 | 24930561 | 34 | 7273553 | 1 | 1 | |
| 2024-04-29 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-04-29 16:15:00 | 9999999995-24-001192 | 333-278810 | 24893794 | 33 | 1889 | ||
| 2024-04-25 | CORRESP | filename1.htm | 0001193125-24-114300 | 16725 | ||||||
| 2024-04-25 | 4 | 4 | 0000950170-24-048457 | 14916 | ||||||
| 2024-04-25 | SC 13D/A | SC 13D/A | 0001193125-24-114056 | 005-89456 | 24877053 | 34 | 87285 | |||
| 2024-04-25 | 8-K | 8-K | 3.02,9.01 | 0001193125-24-113954 | 001-37722 | 24876687 | 34 | 199423 | 1 | 1 |
| 2024-04-25 | UPLOAD | filename1.pdf | 0000000000-24-004609 | 333-278810 | 40453 | |||||
| 2024-04-23 | SC 13G/A | SPYRE THERAPEUTICS INC. | 0000902664-24-003035 | 005-89456 | 24866251 | 34 | 59635 | |||
| 2024-04-19 | S-1 | S-1 | 0001193125-24-101185 | 333-278810 | 24855378 | 33 | 13554199 | 1 | 1 | |
| 2024-04-02 | ARS | ARS | 0001636282-24-000024 | 001-37722 | 24814935 | 34 | 28526233 | |||
| 2024-04-02 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-001517 | 333-276251 | 63930 | |||||
| 2024-04-01 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-24-077783,2024-04-01 | 9999999995-24-000807 | 333-273769 | 24812080 | 33 | 1902 | ||
| 2024-04-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-04-01 16:01:00 | 9999999995-24-000812 | 333-276251 | 24812071 | 33 | 1889 | ||
| 2024-04-01 | DEF 14A | DEF 14A | 0001636282-24-000021 | 001-37722 | 24809164 | 34 | 2744942 | 1 | 1 | |
| 2024-03-28 | CORRESP | filename1.htm | 0001193125-24-080597 | 13720 | ||||||
| 2024-03-27 | POS AM | POS AM | 0001193125-24-077783 | 333-273769 | 24785196 | 33 | 13443105 | 1 | 1 | |
| 2024-03-27 | S-1/A | S-1/A | 0001193125-24-077777 | 333-276251 | 24785187 | 33 | 13420641 | 1 | 1 | |
| 2024-03-26 | CORRESP | filename1.htm | 0001193125-24-077797 | 16382 | ||||||
| 2024-03-20 | PRE 14A | PRE 14A | 0001636282-24-000018 | 001-37722 | 24766276 | 34 | 2761962 | 1 | 1 | |
| 2024-03-18 | 424B3 | 424B3 | 0001193125-24-070131 | 333-273769 | 24759022 | 33 | 484207 | |||
| 2024-03-18 | 8-K | 8-K | 1.01,3.02,5.03,7.01,9.01 | 0001193125-24-069693 | 001-37722 | 24757006 | 34 | 718706 | 1 | 1 |
| 2024-03-14 | CORRESP | filename1.htm | 0001193125-24-067912 | 17832 | ||||||
| 2024-03-14 | POS AM | POS AM | 0001193125-24-067903 | 333-273769 | 24750254 | 33 | 13402559 | 1 | 1 | |
| 2024-03-14 | S-1/A | S-1/A | 0001193125-24-067885 | 333-276251 | 24750181 | 33 | 13381404 | 1 | 1 | |
| 2024-03-11 | SC 13G/A | filing.txt | 0000315066-24-001673 | 005-89456 | 24736626 | 34 | 8386 | |||
| 2024-03-08 | UPLOAD | filename1.pdf | 0000000000-24-002607 | 333-276251 | 43584 | |||||
| 2024-03-05 | POS AM | POS AM | 0001193125-24-059407 | 333-273769 | 24722261 | 33 | 13371165 | 1 | 1 | |
| 2024-03-01 | CORRESP | filename1.htm | 0001193125-24-055983 | 47618 | ||||||
| 2024-03-01 | S-1/A | S-1/A | 0001193125-24-055961 | 333-276251 | 24709921 | 33 | 13867468 | 1 | 1 | |
| 2024-03-01 | 10-K/A | 10-K/A | 0001636282-24-000010 | 001-37722 | 24706756 | 34 | 401312 | 1 | 1 | |
| 2024-02-29 | S-8 | S-8 | 0001193125-24-053633 | 333-277542 | 24704947 | 33 | 69706 | |||
| 2024-02-29 | 8-K | 8-K | 2.02,9.01 | 0001636282-24-000007 | 001-37722 | 24703816 | 34 | 369058 | 1 | 1 |
| 2024-02-29 | 10-K | 10-K | 0001636282-24-000005 | 001-37722 | 24703617 | 34 | 13009125 | 1 | 1 | |
| 2024-02-20 | 4 | 4 | 0000950170-24-017494 | 5062 | ||||||
| 2024-02-16 | UPLOAD | filename1.pdf | 0000000000-24-001873 | 333-276251 | 59707 | |||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024226 | 005-89456 | 24641695 | 34 | 165872 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023876 | 005-89456 | 24639821 | 34 | 55044 | |||
| 2024-02-14 | SC 13G/A | agle13ga.htm | 0000935836-24-000203 | 005-89456 | 24639378 | 34 | 47296 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-036324 | 005-89456 | 24638970 | 34 | 64742 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023722 | 005-89456 | 24638765 | 34 | 99892 | |||
| 2024-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-006628 | 005-89456 | 24637772 | 34 | 87489 | |||
| 2024-02-14 | SC 13G/A | agle13ga.htm | 0000935836-24-000193 | 005-89456 | 24637173 | 34 | 60774 | |||
| 2024-02-14 | SC 13G/A | rocksprings-agle123123a1.htm | 0001172661-24-001205 | 005-89456 | 24635911 | 34 | 89265 | |||
| 2024-02-14 | SC 13G | SPYRE THERAPEUTICS, INC. | 0000902664-24-001596 | 005-89456 | 24632907 | 34 | 62155 | |||
| 2024-02-14 | SC 13G/A | deeptrack-syre123123a1.htm | 0001172661-24-000943 | 005-89456 | 24632735 | 34 | 105863 | |||
| 2024-02-14 | SC 13G | SPYRE THERAPEUTICS, INC. | 0000902664-24-001536 | 005-89456 | 24632196 | 34 | 66266 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-034079 | 005-89456 | 24630859 | 34 | 49168 | |||
| 2024-02-13 | SC 13G/A | d10979554_13g-a.htm | 0000919574-24-001081 | 005-89456 | 24630242 | 34 | 109275 | |||
| 2024-02-13 | SC 13G/A | AMENDMENT TO FORM SC 13G | 0001999371-24-002149 | 005-89456 | 24626950 | 34 | 85309 | |||
| 2024-02-13 | SC 13G/A | polar-syre123123a1.htm | 0001172661-24-000761 | 005-89456 | 24622994 | 34 | 110250 | |||
| 2024-02-12 | SC 13G/A | filing.txt | 0000315066-24-001638 | 005-89456 | 24618415 | 34 | 8391 | |||
| 2024-02-09 | SC 13G | filing.txt | 0000315066-24-001597 | 005-89456 | 24612765 | 34 | 8310 | |||
| 2024-02-08 | SC 13G/A | SYRE_SC13GA2.htm | 0001319244-24-000024 | 005-89456 | 24609673 | 34 | 95940 | |||
| 2024-02-07 | 424B3 | 424B3 | 0001193125-24-025665 | 333-273769 | 24601919 | 33 | 344020 | |||
| 2024-02-05 | 4 | 4 | 0000950170-24-011369 | 5479 | ||||||
| 2024-02-05 | 3 | 3 | 0000950170-24-011360 | 12344 | ||||||
| 2024-02-05 | 8-K | 8-K | 1.01,5.02,5.03,5.05,9.01 | 0001193125-24-023462 | 001-37722 | 24593964 | 34 | 547363 | 1 | 1 |
| 2024-02-05 | S-1/A | S-1/A | 0001193125-24-023071 | 333-276251 | 24593623 | 33 | 16567442 | 1 | 1 | |
| 2024-02-02 | CORRESP | filename1.htm | 0001193125-24-023082 | 93860 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010904 | 5508 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010901 | 5501 | ||||||
| 2024-02-02 | 4 | 4 | 0000950170-24-010896 | 5520 | ||||||
| 2024-01-19 | SEC STAFF LETTER | filename1.pdf | 9999999997-24-000177 | 65059 | ||||||
| 2024-01-18 | UPLOAD | filename1.pdf | 0000000000-24-000701 | 333-276251 | 83688 | |||||
| 2024-01-18 | 8-K | 8-K | 3.01 | 0001193125-24-010226 | 001-37722 | 24542161 | 34 | 147299 | 1 | 1 |
| 2023-12-29 | SC 13D/A | SC 13D/A | 0001193125-23-306010 | 005-89456 | 231528405 | 34 | 118907 | |||
| 2023-12-29 | 4 | 4 | 0000950170-23-073904 | 22407 | ||||||
| 2023-12-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001209191-23-059745 | 021-500772 | 231514494 | 33 | 20915 | ||
| 2023-12-22 | 4 | 4 | 0000950170-23-072763 | 5109 | ||||||
| 2023-12-22 | S-8 | S-8 | 0001193125-23-302201 | 333-276256 | 231510637 | 33 | 330449 | |||
| 2023-12-22 | S-1 | S-1 | 0001193125-23-302158 | 333-276251 | 231510307 | 33 | 21270364 | 1 | 1 | |
| 2023-12-13 | SC 13G | SC 13G | 0001193125-23-294297 | 005-89456 | 231483894 | 34 | 67485 | |||
| 2023-12-11 | 4 | 4 | 0000950170-23-069455 | 15129 | ||||||
| 2023-12-11 | SC 13D/A | SC 13D/A | 0001193125-23-292713 | 005-89456 | 231479027 | 34 | 126646 | |||
| 2023-12-08 | 4/A | 4/A | 0000950170-23-069048 | 9734 | ||||||
| 2023-12-08 | 424B3 | 424B3 | 0001193125-23-291672 | 333-273769 | 231475434 | 33 | 592615 | |||
| 2023-12-08 | 3/A | 3/A | 0000950170-23-069037 | 4777 | ||||||
| 2023-12-08 | 8-K | 8-K | 1.01,3.02,5.03,7.01,9.01 | 0001193125-23-291257 | 001-37722 | 231474016 | 34 | 851494 | 1 | 1 |
| 2023-12-01 | SC 13G | formsc13g.htm | 0001493152-23-043412 | 005-89456 | 231459710 | 34 | 95343 | |||
| 2023-11-30 | 424B3 | 424B3 | 0001193125-23-286398 | 333-273769 | 231456653 | 33 | 223738 | |||
| 2023-11-29 | SC 13D/A | SC 13D/A | 0001193125-23-285257 | 005-89456 | 231453179 | 34 | 120807 | |||
| 2023-11-28 | 4 | 4 | 0000950170-23-066399 | 20422 | ||||||
| 2023-11-28 | 8-K | 8-K | 5.02,5.03,7.01,9.01 | 0001193125-23-283693 | 001-37722 | 231441897 | 34 | 358391 | 1 | 1 |
| 2023-11-27 | 4 | 4 | 0000950170-23-066146 | 5440 | ||||||
| 2023-11-27 | 4 | 4 | 0000950170-23-066143 | 5385 | ||||||
| 2023-11-27 | 3 | 3 | 0000950170-23-066141 | 12031 | ||||||
| 2023-11-27 | 3 | 3 | 0000950170-23-066136 | 10785 | ||||||
| 2023-11-27 | 4 | 4 | 0000950170-23-066131 | 9838 | ||||||
| 2023-11-24 | 8-K | 8-K | 5.03,5.07,7.01,9.01 | 0001193125-23-282424 | 001-37722 | 231434870 | 34 | 179734 | 1 | 1 |
| 2023-11-20 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2023-11-20 16:01:00 | 9999999995-23-003387 | 333-273769 | 231424381 | 33 | 1744 | ||
| 2023-11-17 | CORRESP | filename1.htm | 0001193125-23-279958 | 10324 | ||||||
| 2023-11-15 | CORRESP | filename1.htm | 0001193125-23-277996 | 42943 | ||||||
| 2023-11-15 | S-1/A | S-1/A | 0001193125-23-277992 | 333-273769 | 231411598 | 33 | 6450977 | |||
| 2023-11-15 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-277985 | 001-37722 | 231411536 | 34 | 798690 | 1 | 1 |
| 2023-11-14 | SC 13G | SCHEDULE 13G | 0001683168-23-008109 | 005-89456 | 231404973 | 34 | 46235 | |||
| 2023-11-09 | 10-Q | 10-Q | 0001636282-23-000018 | 001-37722 | 231392497 | 34 | 8182037 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,9.01 | 0001636282-23-000016 | 001-37722 | 231392340 | 34 | 290879 | 1 | 1 |
| 2023-10-27 | DEF 14A | DEF 14A | 0001193125-23-264329 | 001-37722 | 231351785 | 34 | 1928197 | |||
| 2023-10-26 | CORRESP | filename1.htm | 0001193125-23-264241 | 70854 | ||||||
| 2023-10-24 | UPLOAD | filename1.pdf | 0000000000-23-011612 | 39966 | ||||||
| 2023-10-24 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-261221 | 001-37722 | 231341273 | 34 | 14618252 | 1 | 1 |
| 2023-10-20 | UPLOAD | filename1.pdf | 0000000000-23-011518 | 43978 | ||||||
| 2023-10-10 | S-1/A | S-1/A | 0001193125-23-252528 | 333-273769 | 231315306 | 33 | 3233499 | |||
| 2023-10-10 | PRER14A | PRER14A | 0001193125-23-252525 | 001-37722 | 231315301 | 34 | 2996787 | |||
| 2023-10-10 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-23-252523 | 001-37722 | 231315300 | 34 | 232674 | 1 | 1 |
| 2023-10-06 | CORRESP | filename1.htm | 0001193125-23-252530 | 105563 | ||||||
| 2023-10-06 | CORRESP | filename1.htm | 0001193125-23-252526 | 70243 | ||||||
| 2023-10-05 | 8-K | 8-K | 1.01 | 0001193125-23-251664 | 001-37722 | 231312138 | 34 | 152061 | 1 | 1 |
| 2023-09-29 | UPLOAD | filename1.pdf | 0000000000-23-010855 | 43749 | ||||||
| 2023-09-25 | 8-K | 8-K | 1.01,3.01,5.02,9.01 | 0001193125-23-241316 | 001-37722 | 231275841 | 34 | 233007 | 1 | 1 |
| 2023-09-08 | CORRESP | filename1.htm | 0001193125-23-231678 | 35682 | ||||||
| 2023-09-08 | 8-K | 8-K | 3.03,5.03,7.01,8.01,9.01 | 0001193125-23-231646 | 001-37722 | 231246029 | 34 | 7261290 | 1 | 1 |
| 2023-09-05 | 4 | 4 | 0000950170-23-046396 | 5467 | ||||||
| 2023-09-05 | 3 | 3 | 0000950170-23-046385 | 6605 | ||||||
| 2023-09-05 | 4 | 4 | 0000950170-23-046384 | 5439 | ||||||
| 2023-09-05 | 3 | 3 | 0000950170-23-046380 | 6596 | ||||||
| 2023-09-05 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-23-228076 | 001-37722 | 231234118 | 34 | 327914 | 1 | 1 |
| 2023-08-28 | UPLOAD | filename1.pdf | 0000000000-23-009459 | 44848 | ||||||
| 2023-08-11 | 10-Q | 10-Q | 0000950170-23-041590 | 001-37722 | 231161488 | 34 | 13684124 | 1 | 1 | |
| 2023-08-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-041586 | 001-37722 | 231161483 | 34 | 471859 | 1 | 1 |
| 2023-08-11 | 8-K | 8-K | 1.02 | 0001193125-23-209727 | 001-37722 | 231161482 | 34 | 148060 | 1 | 1 |
| 2023-08-08 | PRE 14A | PRE 14A | 0001193125-23-205262 | 001-37722 | 231149125 | 34 | 1892144 | |||
| 2023-08-07 | S-3 | S-3 | 0001193125-23-205011 | 333-273769 | 231147951 | 33 | 2242641 | |||
| 2023-07-28 | SC 13G | polar-agle071923.htm | 0001172661-23-002651 | 005-89456 | 231120373 | 34 | 110057 | |||
| 2023-07-27 | 8-K | 8-K | 1.01,1.02,2.01,7.01,8.01,9.01 | 0001193125-23-195289 | 001-37722 | 231115242 | 34 | 179318 | 1 | 1 |
| 2023-07-18 | SC 13G | agle13g.htm | 0000935836-23-000523 | 005-89456 | 231094249 | 34 | 61427 | |||
| 2023-07-14 | 8-K | 8-K | 3.01 | 0001193125-23-187257 | 001-37722 | 231089176 | 34 | 184203 | 1 | 1 |
| 2023-07-10 | SC 13G | SC 13G | 0001104659-23-079663 | 005-89456 | 231079916 | 34 | 175736 | |||
| 2023-07-06 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-23-000044 | 021-486102 | 231073584 | 33 | 19550 | ||
| 2023-07-03 | SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001839882-23-017505 | 005-89456 | 231065465 | 34 | 98520 | |||
| 2023-06-30 | 3 | 3 | 0000950170-23-031185 | 20706 | ||||||
| 2023-06-30 | SC 13D | SC 13D | 0001193125-23-180612 | 005-89456 | 231062842 | 34 | 147416 | |||
| 2023-06-30 | 3 | 3 | 0000950170-23-031168 | 14859 | ||||||
| 2023-06-30 | 3 | 3 | 0000950170-23-031167 | 12735 | ||||||
| 2023-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-040338 | 5833 | ||||||
| 2023-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-040335 | 5796 | ||||||
| 2023-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-040333 | 5971 | ||||||
| 2023-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-040329 | 5768 | ||||||
| 2023-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-040328 | 5842 | ||||||
| 2023-06-30 | SC 13G | agle13g.htm | 0000935836-23-000494 | 005-89456 | 231062021 | 34 | 47226 | |||
| 2023-06-30 | SC 13G | deeptrack-agle062223.htm | 0001172661-23-002388 | 005-89456 | 231061552 | 34 | 105717 | |||
| 2023-06-23 | 8-K | 8-K | 1.01,2.01,3.02,5.02,5.03,7.01,9.01 | 0001193125-23-173242 | 001-37722 | 231035065 | 34 | 8235632 | 1 | 1 |
| 2023-06-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-172698 | 001-37722 | 231034220 | 34 | 193964 | 1 | 1 |
| 2023-06-09 | 8-K | 8-K | 5.07 | 0001193125-23-164444 | 001-37722 | 231005282 | 34 | 163175 | 1 | 1 |
| 2023-05-19 | DEFA14A | DEFA14A | 0001193125-23-149311 | 001-37722 | 23940116 | 34 | 11473 | |||
| 2023-05-19 | 8-K | 8-K | 5.02 | 0001193125-23-149301 | 001-37722 | 23940059 | 34 | 147258 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-020825 | 001-37722 | 23908762 | 34 | 7514388 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-020819 | 001-37722 | 23908746 | 34 | 471172 | 1 | 1 |
| 2023-04-25 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-23-115402 | 001-37722 | 23845293 | 34 | 15739817 | 1 | 1 |
| 2023-04-17 | ARS | ARS | 0001193125-23-103763 | 001-37722 | 23824538 | 34 | 773156 | |||
| 2023-04-17 | DEF 14A | DEF 14A | 0001193125-23-103731 | 001-37722 | 23824483 | 34 | 983960 | |||
| 2023-04-12 | 8-K | 8-K | 2.05,5.02,8.01,9.01 | 0001193125-23-098539 | 001-37722 | 23814739 | 34 | 184307 | 1 | 1 |
| 2023-04-07 | PRE 14A | PRE 14A | 0001193125-23-095201 | 001-37722 | 23808798 | 34 | 983736 | |||
| 2023-03-13 | 8-K | 8-K | 8.01 | 0001193125-23-068397 | 001-37722 | 23725577 | 34 | 148057 | 1 | 1 |
| 2023-03-02 | S-8 | S-8 | 0001193125-23-057310 | 333-270208 | 23696463 | 33 | 90136 | |||
| 2023-03-02 | 424B5 | 424B5 | 0001193125-23-057268 | 333-239706 | 23696410 | 33 | 119462 | |||
| 2023-03-02 | 10-K | 10-K | 0000950170-23-005705 | 001-37722 | 23696398 | 34 | 15286070 | 1 | 1 | |
| 2023-03-02 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-23-005699 | 001-37722 | 23696384 | 34 | 20084437 | 1 | 1 |
| 2023-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-012882 | 5533 | ||||||
| 2023-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-012881 | 5499 | ||||||
| 2023-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-012877 | 5550 | ||||||
| 2023-02-24 | 4 | FORM 4 SUBMISSION | 0001209191-23-012875 | 5541 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021874 | 005-89456 | 23631026 | 34 | 56541 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 6 | 0000947871-23-000163 | 005-89456 | 23628475 | 34 | 58447 | |||
| 2023-02-14 | SC 13G | SC 13G | 0001104659-23-021466 | 005-89456 | 23628436 | 34 | 126183 | |||
| 2023-02-14 | SC 13G | rocksprings-agle123122.htm | 0001172661-23-001246 | 005-89456 | 23627512 | 34 | 88916 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-036871 | 005-89456 | 23621740 | 34 | 45004 | |||
| 2023-02-13 | SC 13G/A | d9082020_13g-a.htm | 0000919574-23-000935 | 005-89456 | 23614946 | 34 | 109929 | |||
| 2023-02-03 | SC 13G | SC 13G | 0001193125-23-023699 | 005-89456 | 23584487 | 34 | 34945 | |||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0001209191-23-005351 | 5585 | ||||||
| 2023-01-27 | 3 | FORM 3 SUBMISSION | 0001209191-23-005349 | 12229 | ||||||
| 2023-01-18 | 8-K | 8-K | 3.01 | 0000950170-23-000840 | 001-37722 | 23532900 | 34 | 173049 | 1 | 1 |
| 2023-01-10 | SC 13G/A | AGLE_SC13GA1_2023.htm | 0001319244-23-000001 | 005-89456 | 23521577 | 34 | 95695 | |||
| 2023-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-004150 | 001-37722 | 23516576 | 34 | 16064471 | 1 | 1 |
| 2023-01-06 | 8-K | 8-K | 5.02 | 0001193125-23-002979 | 001-37722 | 23513755 | 34 | 145942 | 1 | 1 |
| 2022-12-19 | 8-K | 8-K | 5.03,9.01 | 0001193125-22-308316 | 001-37722 | 221471116 | 34 | 355221 | 1 | 1 |
| 2022-12-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-059262 | 5588 | ||||||
| 2022-12-01 | 3 | FORM 3 SUBMISSION | 0001209191-22-059261 | 6063 | ||||||
| 2022-12-01 | SC 13G | AGLE_SC13G.htm | 0001319244-22-000177 | 005-89456 | 221438906 | 34 | 95662 | |||
| 2022-11-30 | 8-K | 8-K | 5.02 | 0001193125-22-294899 | 001-37722 | 221434294 | 34 | 151114 | 1 | 1 |
| 2022-11-15 | 8-K | 8-K | 8.01 | 0001193125-22-285197 | 001-37722 | 221389237 | 34 | 143814 | 1 | 1 |
| 2022-11-03 | 10-Q | 10-Q | 0000950170-22-021529 | 001-37722 | 221356147 | 34 | 9557365 | 1 | 1 | |
| 2022-11-03 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-22-021527 | 001-37722 | 221356132 | 34 | 4391819 | 1 | 1 |
| 2022-10-04 | 8-K | 8-K | 8.01 | 0001193125-22-257184 | 001-37722 | 221289710 | 34 | 148946 | 1 | 1 |
| 2022-09-06 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-239029 | 001-37722 | 221228934 | 34 | 16404841 | 1 | 1 |
| 2022-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-047656 | 5851 | ||||||
| 2022-08-25 | 3 | FORM 3 SUBMISSION | 0001209191-22-047655 | 9230 | ||||||
| 2022-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-047653 | 4513 | ||||||
| 2022-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-047651 | 5839 | ||||||
| 2022-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-047649 | 5884 | ||||||
| 2022-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-047648 | 5875 | ||||||
| 2022-08-25 | 8-K | 8-K | 5.02,8.01 | 0001193125-22-229043 | 001-37722 | 221192891 | 34 | 165852 | 1 | 1 |
| 2022-08-18 | 8-K | 8-K | 8.01 | 0001193125-22-224107 | 001-37722 | 221177550 | 34 | 151211 | 1 | 1 |
| 2022-08-04 | 10-Q | 10-Q | 0001564590-22-027895 | 001-37722 | 221134453 | 34 | 9106395 | 1 | 1 | |
| 2022-08-04 | 8-K | 8-K 2Q22 | 2.02,7.01,9.01 | 0001564590-22-027893 | 001-37722 | 221134432 | 34 | 11099383 | 1 | 1 |
| 2022-07-19 | 8-K | 8-K | 3.01 | 0001193125-22-196966 | 001-37722 | 221091629 | 34 | 151268 | 1 | 1 |
| 2022-07-07 | 8-K | 8-K | 5.02 | 0001193125-22-189446 | 001-37722 | 221071728 | 34 | 143158 | 1 | 1 |
One latest value per concept from companyfacts (350 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 94.97M | 2026-10-27 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.10B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 3.14M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001636282-26-000039 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.20M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001636282-26-000039 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001636282-26-000039 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 16.65 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-10 | 0001636282-26-000039 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 35,017.51 | 2026-10-06 | 424B5 | 2026-10-06 | 0001628280-26-065249 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 35,017.51 | 2026-10-06 | 424B5 | 2026-10-06 | 0001628280-26-065249 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 402.50M | 2026-10-06 | 424B5 | 2026-10-06 | 0001628280-26-065249 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-10-06 | 424B5 | 2026-10-06 | 0001628280-26-065249 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-10-06 | 424B5 | 2026-10-06 | 0001628280-26-065249 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.85M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 | |
| us-gaap | AccountsPayableOtherCurrent | Accounts Payable, Other, Current | USD | 15.53M | 2024-03-31 | 2024 | Q1 | 10-Q/A | 2024-11-18 | 0001636282-24-000109 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 20.81M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 5.17M | 2024-09-30 | 2024 | Q3 | 10-Q/A | 2024-11-18 | 0001636282-24-000113 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 9.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 30.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 2.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 7.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -5.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 250.30M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-07 | 0001564590-19-016211 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 2.24B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 2.49M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 14.46M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 800,000 | 2020-04-01 | 2020-04-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-050906 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 40.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | AreaOfLand | Area of Land | sqft | 30,000 | 2019-04-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | AssetAcquisitionConsiderationTransferred | AssetAcquisitionConsiderationTransferred | USD | 113.20M | 2023-06-22 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001636282-23-000018 | |
| us-gaap | AssetAcquisitionConsiderationTransferredTransactionCost | AssetAcquisitionConsiderationTransferredTransactionCost | USD | 3.20M | 2023-06-22 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | Assets | Assets | USD | 1.10B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.10B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 1.06B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AssetsFairValueDisclosureRecurring | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | USD | 40.34M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011484 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 12,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 5.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 994.56M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 50.20M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001564590-18-028293 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 4,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028480 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 17,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054228 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 32.81M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011484 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 52.79M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054228 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 17,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054228 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 52.79M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054228 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five | USD | 229.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 688.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 52.70M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 989.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | BilledContractReceivables | Billed Contracts Receivable | USD | 2.40M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001564590-18-028293 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 2.07M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 |
| us-gaap | CapitalUnitsAuthorized | Capital Units, Authorized | shares | 510.00M | 2016-04-12 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022228 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 82.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 71.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 7.76M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020760 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 1.10B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 82.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 236.68M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -2.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 71.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.003 | 2022-05-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 694,892 | 2022-05-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 400.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 89.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 89.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 16,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -207.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ContractWithCustomerAssetNet | Contract with Customer, Asset, after Allowance for Credit Loss | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination | USD | -3.27M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 21.50M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-04 | 0001564590-21-054228 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 9.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ConversionOfStockAmountIssued1 | Conversion of Stock, Amount Issued | USD | 202.18M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 |
| us-gaap | DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss | Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss | USD | 4.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 932.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 5.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGainLoss | Debt Securities, Available-for-sale, Realized Gain (Loss) | USD | 300,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | 700,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 932.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 5.39M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 38 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001564590-22-027895 | |
| us-gaap | DecreaseInRestrictedCash | Decrease in Restricted Cash | USD | 80,000 | 2016-01-01 | 2016-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001564590-17-022228 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 183,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 2.54M | 2015-12-31 | 2016 | FY | 10-K | 2017-03-23 | 0001564590-17-005137 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 930,000 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 2.34M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 | |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 4.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 201.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 118.51M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 87,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 12.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 1.63M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 201.34M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities | Deferred Tax Liabilities, Unrealized Gains on Trading Securities | USD | 183,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 800,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 600,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -1.44M | 2014-01-01 | 2014-12-31 | 2016 | FY | 10-K | 2017-03-23 | 0001564590-17-005137 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 6.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 6.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationConsideration | Disposal Group, Including Discontinued Operation, Consideration | USD | 500,000 | 2023-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | DisposalGroupNotDiscontinuedOperationGainLossOnDisposal | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | USD | 70.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | Dividends | Dividends | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-23 | 0001564590-17-005137 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | 2.39 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q/A | 2024-11-18 | 0001636282-24-000113 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.37 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018006 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -2.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.242 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.005 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount | USD | -2.52M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | 0.016 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense | Share-based Payment Arrangement, Expense, Tax Benefit | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ExpenseRelatedToDistributionOrServicingAndUnderwritingFees | Expense Related to Distribution or Servicing and Underwriting Fees | USD | 8.20M | 2020-04-01 | 2020-04-30 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0001564590-22-008995 | |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 0.7 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | FairValueInputsDiscountRate | Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) | pure | 0.3 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 0 | 2022-12-31 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001636282-23-000018 | |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 16,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 16,000 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 16,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 16,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 17,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014021 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 16,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0001564590-22-008995 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 9,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001564590-19-040692 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 6,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0001564590-22-008995 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 0 | 2022-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | GainLossOnDerivativeInstrumentsNetPretax | Gain (Loss) on Derivative Instruments, Net, Pretax | USD | -35.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 47.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | GrantsReceivableCurrent | Grants Receivable, Current | USD | 3.08M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006771 | |
| us-gaap | HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss | Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss | USD | 34,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 34,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | ImpairmentOfLeasehold | Impairment of Leasehold | USD | 1.70M | 2023-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -155.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -201.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 37,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -83.95M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | -15,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | IncomeTaxPaidFederalAfterRefundReceived | IncomeTaxPaidFederalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxPaidForeignAfterRefundReceived | IncomeTaxPaidForeignAfterRefundReceived | USD | -15,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxPaidStateAndLocalAfterRefundReceived | IncomeTaxPaidStateAndLocalAfterRefundReceived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 37.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 1.86M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | -23,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -32.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 773,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 10,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationOtherReconcilingItems | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount | USD | 114,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.04M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-11 | 0000950170-23-041590 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 562,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 4.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncreaseDecreaseInDeferredCharges | Increase (Decrease) in Deferred Charges | USD | -5,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001564590-17-009615 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -20,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-08 | 0001564590-18-028293 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayable | Increase (Decrease) in Other Accounts Payable | USD | 68,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 5.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | -80,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006771 |
| us-gaap | IncreaseDecreaseInSecurityDeposits | Increase (Decrease) in Security Deposits | USD | -18,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028480 |
| us-gaap | IncreaseInRestrictedCash | Increase in Restricted Cash | USD | 75,000 | 2016-01-01 | 2016-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001564590-17-016937 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 116,788 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001636282-24-000083 |
| us-gaap | InterestCostsIncurred | Interest Costs Incurred | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0001564590-22-008995 |
| us-gaap | InvestmentIncomeAmortizationOfPremium | Investment Income, Amortization of Premium | USD | 75,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 27.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | InvestmentIncomeNetAmortizationOfDiscountAndPremium | Investment Income, Net, Amortization of Discount and Premium | USD | 593,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006771 |
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 107,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 10-K | 2021-03-18 | 0001564590-21-014021 |
| us-gaap | LeaseCost | Lease, Cost | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 6.07M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 403,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.08M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 1.20M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.16M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.13M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.10M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 169,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-06 | 0001564590-19-040692 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.45M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | Liabilities | Liabilities | USD | 48.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.10B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 40.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 6.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 486.20M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001636282-25-000102 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 38.07M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-07 | 0001564590-19-016211 | |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 0 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 446.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 38.75M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020760 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -245.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -14.50M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020760 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -204.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -16.49M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-09 | 0001564590-18-020760 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -201.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -27.24M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -8.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | NontradeReceivablesCurrent | Nontrade Receivables, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 193.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -193.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.30M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 900,000 | 2023-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 4.63M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 889,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 397,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 301,000 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028480 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 300,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001564590-17-009615 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 83,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 409,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 314,000 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001564590-17-009615 | |
| us-gaap | OperatingLeasesRentExpenseNet | Operating Leases, Rent Expense, Net | USD | 400,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006771 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 560.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 144,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -6.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -36.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | Other Significant Noncash Transaction, Value of Consideration Given | USD | 232,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | PartnersCapitalAccountDistributions | Partners' Capital Account, Distributions | USD | 0 | 2015-03-09 | 2015-03-10 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 5.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | PaymentsForDerivativeInstrumentFinancingActivities | Payments for Derivative Instrument, Financing Activities | USD | 1.43M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 5.30M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 800,000 | 2020-04-01 | 2020-04-30 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 666.79M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 19.75M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-07 | 0001564590-19-016211 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | PreferredStockDividendRatePercentage | Preferred Stock, Dividend Rate, Percentage | pure | 0.08 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-23 | 0001564590-17-005137 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2024-03-31 | 2024 | Q1 | 10-Q/A | 2024-11-18 | 0001636282-24-000109 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2024-03-31 | 2024 | Q1 | 10-Q/A | 2024-11-18 | 0001636282-24-000109 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0001636282-23-000018 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 27.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 42.90M | 2022-05-01 | 2022-05-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 169.21M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q/A | 2024-11-18 | 0001636282-24-000109 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 435.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised | USD | 28.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 96,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-09 | 0001564590-17-009615 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 351.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 33.80M | 2019-01-01 | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-07 | 0001564590-19-016211 |
| us-gaap | ProceedsFromSaleOfIntangibleAssets | Proceeds from Sale of Intangible Assets | USD | 70.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 76,000 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028480 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -151.72M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q/A | 2024-11-18 | 0001636282-24-000113 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 0 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | ReceivablesNetCurrent | Receivables, Net, Current | USD | 21.50M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001564590-21-025791 | |
| us-gaap | ReimbursementFromLimitedPartnershipInvestment | Reimbursement from Limited Partnership Investment | USD | 3.00M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-08 | 0001564590-22-008995 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 13.78M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-020825 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 215.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 80,000 | 2015-12-31 | 2016 | FY | 10-K | 2017-03-23 | 0001564590-17-005137 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.83 | 2023-04-12 | 2023-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.33B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 0 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-10 | 0001564590-21-025791 |
| us-gaap | RevenueFromGrants | Revenue from Grants (Deprecated 2018-01-31) | USD | 1.51M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-08 | 0001564590-18-011484 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 4.75 | 2020-04-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-050906 | |
| us-gaap | SecurityDeposit | Security Deposit | USD | 1.50M | 2019-04-30 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | SecurityDepositLiability | Security Deposit Liability | USD | 48,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-07 | 0001564590-19-006771 | |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 6.40M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 40.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 1.00M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 38,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.87 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-19 | 0001564590-16-019683 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.013 | 2016-01-01 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-19 | 0001564590-16-019683 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 95.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 5.16M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 14.5 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 198,455 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 2.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 191.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 11.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 16.06 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 191.20M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 11.37M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 16.06 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected | Share-based Payment Arrangement, Plan Modification, Number of Grantees Affected | Employee | 7 | 2015-03-09 | 2015-03-10 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 8.68 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 33.38 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 34.81 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 1.05B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.095 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 307,673 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 189.74M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 0 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 222,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 29.52M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | StockIssuedDuringPeriodValuePurchaseOfAssets | Stock Issued During Period, Value, Purchase of Assets | USD | 3.77M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 14.17M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-03 | 0001636282-26-000131 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 1.45M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-02 | 0000950170-23-005705 |
| us-gaap | TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit | Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001564590-20-005888 |
| us-gaap | TemporaryEquityAggregateAmountOfRedemptionRequirement | Temporary Equity, Aggregate Amount of Redemption Requirement | USD | 129.10M | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | TemporaryEquityDividendsAdjustment | Temporary Equity, Dividends, Adjustment | USD | 228,000 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-03-13 | 0001564590-18-005404 |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | TemporaryEquityRedemptionPricePerShare | Temporary Equity, Redemption Price Per Share | USD/shares | 21.52 | 2023-12-31 | 2023 | FY | 10-K/A | 2024-11-18 | 0001636282-24-000107 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 150,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 150,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 | |
| us-gaap | TemporaryEquityStockIssuedDuringPeriodValueNewIssues | Temporary Equity, Stock Issued During Period, Value, New Issues | USD | 168.85M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-27 | 0001636282-25-000020 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 120,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018006 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-09 | 0001564590-16-028480 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 38.40M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001636282-26-000020 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 44.26M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q/A | 2024-11-18 | 0001636282-24-000113 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 66.00M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-05 | 0001564590-22-018006 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 44.15M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-07 | 0001636282-24-000083 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 44.26M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q/A | 2024-11-18 | 0001636282-24-000113 |